| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |